arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Coya Therapeutics, Inc.

COYA

$4.80 ▲ +0.23 (+5.03%) at close

19 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Coya Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $108.7M

Dividend Yield —

Revenue Growth -2.6% ↘

Op. Margin None

ROIC -12.3% ↘

FCF / Share $-0.27

Trailing P/E —

Price / Book 2.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

19-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$251.15K

↓ -2.6% —

Net Income Profit after all expenses

$-7.21M

↑ +1.4% —

Operating Margin Operating profit as % of sales

-152.3%

↓ -123.1% 0th

FCF / Share Free cash flow per share

$-0.27

↓ -62.1% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	-2.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-133%)	202768.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2534510%)	—	-95.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1290%)	103.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1191%)	-100.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1350%)	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	27.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-88.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	50.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-89.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-25.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	23.5% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	38.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-25.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	78.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	76.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	57.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	1.4% Caution ↑ Caution Improving Year-over-year change in net income	-95.8% Weak ↓ Weak Declining Year-over-year change in net income	-44.6% Weak → Weak Stable Year-over-year change in net income	-44.6% Weak ↑ Weak Improving Year-over-year change in net income	-44.6% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-84.6% Weak → Weak Stable Year-over-year change in net income	-84.6% Weak ↓ Weak Declining Year-over-year change in net income	-84.6% Weak ↓ Weak Declining Year-over-year change in net income	N/M	-60.6% Weak → Weak Stable Year-over-year change in net income	-60.6% Weak Weak Year-over-year change in net income	-60.6% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	-62.1% Weak Weak Year-over-year change in free cash flow	—	—	—	N/M	—	—	—	N/M	—	—	—	48.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Operating Margin (%) (%)	—	-152.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1115%)	-68.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-555%)	—	—	—	—	-94.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-730%)	—	30.2% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+102%)	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	-144.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1301%)	-205.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1808%)	—	—	—	—	-147.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1329%)	—	21.1% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+76%)	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	-25.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-31.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	-37.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.18x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.15x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.39x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	-0.42x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-1.77x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.41x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	-12.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	4.0% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	-27.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	18.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	39.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	193.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-68.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-14.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	4.4% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-30.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-23.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-14.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-198%)	-13.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-188%)	-26.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-279%)	-25.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-272%)	-21.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-246%)	-7.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-149%)	-15.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-205%)	-14.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-196%)	-15.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-204%)	3.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-76%)	-27.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-281%)	-20.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-238%)	-16.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-213%)	37.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+147%)	31.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+112%)	121.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+707%)	-86.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-679%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Net Debt (USD)	$-50.72M	$-46.82M	$-28.13M	$-29.76M	$-35.53M	$-38.34M	$-31.06M	$-36.58M	$-35.99M	$-32.63M	$-10.89M	$-13.10M	$-16.32M	$-5.93M	—	—	—	$-4.34M	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Revenue per Share (USD)	$0.01	—	$0.21	$0.01	$0.02	—	$0.00	$0.23	$0.01	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.32	$-0.34	$-0.13	$-0.36	$-0.44	$-0.18	$-0.26	$-0.19	$-0.35	$0.15	$-0.34	$-0.31	$-0.28	$-1.20	$-1.55	$-1.32	$-0.66	—	—
Free Cash Flow per Share (USD)	$-0.27	—	$-0.07	$-0.35	$-0.17	—	—	—	$0.15	—	—	—	$-0.40	—	$-0.61	$-0.56	$-0.77	—	—
Book Value per Share (USD)	$2.09	$2.06	$1.63	$1.69	$2.00	$2.37	$2.10	$2.32	$2.22	$2.47	$1.01	$1.33	$1.62	$-3.24	$-2.07	$-0.54	$0.76	$1.41	—
Tangible Book Value per Share (USD)	$2.09	$2.06	$1.63	$1.69	$2.00	$2.37	$2.10	$2.32	$2.22	$2.47	$1.01	$1.33	$1.62	$-3.24	$-2.07	$-0.54	$0.76	$1.41	—
Basic Weighted Avg Shares (shares)	22.64M	—	16.73M	16.72M	16.72M	—	15.22M	14.92M	14.46M	—	9.95M	9.95M	9.72M	—	2.59M	2.59M	2.59M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$49.72M	$44.07M	$28.36M	$28.93M	$34.03M	$40.48M	$33.19M	$36.06M	$33.02M	$36.14M	$10.02M	$13.17M	$16.07M	$3.36M	—	—	—	$3.44M	—
Total Equity (USD)	$48.97M	$43.03M	$27.28M	$28.31M	$33.37M	$39.58M	$32.01M	$35.26M	$32.39M	$35.64M	$10.09M	$13.25M	$16.15M	$-8.39M	$-5.36M	$-1.41M	$1.96M	$3.64M	$8.30M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$251.15K	$3.96M	$3.56M	$163.62K	$257.88K	$1.95K	$0.00	$3.43M	$126.84K	$6.00M	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$2.81K	$6.84K	$6.84K	$6.84K	$6.84K	$6.84K	$6.84K	$6.84K	$6.84K	$6.84K	$6.84K	$6.84K	$6.84K	$6.84K	$12.46K	$4.03K	$4.03K	—	—
Net Income, GAAP (USD)	$-7.21M	$-5.71M	$-7.31M	$-7.31M	$-7.31M	$-2.92M	$-5.05M	$-5.05M	$-5.05M	$1.27M	$-2.74M	$-2.74M	$-2.74M	$-3.11M	$-1.70M	$-1.70M	$-1.70M	—	—
Operating Cash Flow (USD)	$-6.21M	$-1.01M	$-1.13M	$-5.77M	$-2.83M	$-2.41M	—	—	$2.15M	$-2.24M	—	—	$-3.86M	$-2.22M	$-1.59M	$-1.44M	$-1.98M	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 19 quarters

Coya Therapeutics, Inc.

Analytical Summary

19-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare COYA with peers